Published in Arch Intern Med on May 01, 1988
Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008. Circulation (2011) 3.95
Thiazide-type diuretics and beta-adrenergic blockers as first-line drug treatments for hypertension. Circulation (2008) 2.06
Measuring adherence to practice guidelines for the management of hypertension: an evaluation of the literature. Hypertension (2004) 1.70
Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics. Circulation (2008) 1.44
Race differences in access to health care and disparities in incident chronic kidney disease in the US. Nephrol Dial Transplant (2010) 1.09
2014 hypertension recommendations from the eighth joint national committee panel members raise concerns for elderly black and female populations. J Am Coll Cardiol (2014) 1.08
Determinants of locomotor disability in people aged 55 years and over: the Rotterdam Study. Eur J Epidemiol (2001) 1.04
First-line first? Trends in thiazide prescribing for hypertensive seniors. PLoS Med (2005) 0.98
Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging. Age (Dordr) (2011) 0.92
Failure of evidence-based medicine in the treatment of hypertension in older patients. J Gen Intern Med (2000) 0.91
Perindopril. A review of its pharmacokinetics and clinical pharmacology. Drugs (1990) 0.91
Manifestations of metabolic syndrome associated with male gout in different age strata. Clin Rheumatol (2007) 0.90
Thirty-year Survival for Black and White Hypertensive Individuals in the Evans County Heart Study and the Hypertension Detection and Follow-up Program. J Am Soc Hypertens (2010) 0.86
Blood pressure lowering in patients with diabetes--one level might not fit all. Nat Rev Cardiol (2010) 0.86
Severity of gouty arthritis is associated with Q-wave myocardial infarction: a large-scale, cross-sectional study. Clin Rheumatol (2006) 0.85
Impact of prehypertension on left ventricular structure, function and geometry. J Clin Diagn Res (2014) 0.85
Racial differences in antihypertensive therapy: evidence and implications. Cardiovasc Drugs Ther (1990) 0.83
Mortality risk prediction by an insurance company and long-term follow-up of 62,000 men. PLoS One (2009) 0.83
Cilazapril. A review. Drugs (1991) 0.83
Hypertension in pregnancy: is it time for a new approach to treatment? J Hypertens (2012) 0.82
A double-blind placebo-controlled study of the effectiveness and tolerability of oral stevioside in human hypertension. Br J Clin Pharmacol (2000) 0.82
Low dose loop diuretics in essential hypertension. Experience with torasemide. Drugs (1991) 0.78
Characteristics of gouty arthritis in the Guatemalan population. Clin Rheumatol (1997) 0.78
Increased risk for cardiovascular outcomes and effect of cholesterol-lowering pravastatin therapy in patients with diabetes mellitus in the pravastatin anti-atherosclerosis trial in the elderly (PATE). Curr Ther Res Clin Exp (2005) 0.78
Risk-benefit aspects of antihypertensive drugs. Drugs (1992) 0.77
Cardiovascular manifestations of anabolic steroids in association with demographic variables in body building athletes. J Res Med Sci (2015) 0.77
The relationship between race, cigarette smoking and carotid intimal medial thickness in systemic lupus erythematosus. Lupus (2009) 0.77
Individualised selection of antihypertensive therapy. Drugs (1993) 0.77
Three in one: safety, efficacy, and patient acceptability of triple fixed-dose combination medicine in the management of hypertension. Patient Prefer Adherence (2012) 0.77
Hypertension research program at ochsner: a program in translational research. Ochsner J (2002) 0.76
Discrepancies in office and ambulatory blood pressure in adolescents: help or hindrance? Pediatr Nephrol (2007) 0.75
Management of cerebral infarction or transient ischemic attacks. Arch Intern Med (1990) 0.75
Beta-blockers and cimetidine. Arch Intern Med (1990) 0.75
Diuretics: again the first step in the treatment of most patients with hypertension. Curr Control Trials Cardiovasc Med (2001) 0.75
Cimetidine and beta-blockers. Arch Intern Med (1989) 0.75
Association of eNOS and Cav-1 gene polymorphisms with susceptibility risk of large artery atherosclerotic stroke. PLoS One (2017) 0.75
Systolic hypertension in the elderly. Cardiovasc Drugs Ther (1991) 0.75
Is salt restriction necessary in hypertensive patients treated with calcium antagonists? Drugs (1992) 0.75
Perioperative Inotrope Therapy and Atrial Fibrillation Following Coronary Artery Bypass Graft Surgery: Evidence of a Racial Disparity. Pharmacotherapy (2017) 0.75
Controversies in the use of combination therapy in the older patient. Drugs (1990) 0.75
A cooperative study to evaluate the efficacy and safety of enalapril in Puerto Rican patients with mild to moderate hypertension. Drugs (1990) 0.75
Effects of angiotensin converting enzyme inhibitors on left ventricular hypertrophy. Drugs (1993) 0.75
Comparative cardiovascular effects of drugs used for hypertension. Drugs (1990) 0.75
Enalaprilat, but not cilazaprilat, increases inflammatory skin reactions in guinea-pigs. Drugs (1991) 0.75
Reflections on the U.S. Preventive Services Task Force recommendations for screening for hypertension and hypercholesterolemia. J Gen Intern Med (1990) 0.75
Primary prevention potential of the calcium antagonists. Effects on blood pressure and lipid pattern. Drugs (1992) 0.75